Advertisement

 

 

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.

Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs.
Author Information (click to view)

Piggott DA, Erlandson KM, Yarasheski KE,


Piggott DA, Erlandson KM, Yarasheski KE, (click to view)

Piggott DA, Erlandson KM, Yarasheski KE,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Current HIV/AIDS reports 2016 8 22()

Abstract

Frailty is a critical aging-related syndrome marked by diminished physiologic reserve and heightened vulnerability to stressors, predisposing to major adverse clinical outcomes, including hospitalization, institutionalization, disability, and death in the general population of older adults. As the proportion of older adults living with HIV increases in the era of antiretroviral therapy, frailty is increasingly recognized to be of significant clinical and public health relevance to the HIV-infected population. This article reviews current knowledge on the epidemiology and biology of frailty and its potential role as a target for reducing disparities in outcomes in HIV; conceptual frameworks and current approaches to frailty measurement; existing data on frailty interventions; and important areas for future research focus necessary to develop and advance effective strategies to prevent or ameliorate frailty and its marked adverse consequences among people living with HIV.

Submit a Comment

Your email address will not be published. Required fields are marked *

1 + eighteen =

[ HIDE/SHOW ]